Investor consortium to take biopharma firm Syneos Health private for $7.1bn

According to the terms of the deal, shareholders will receive $43 per share in cash.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this